List of Tables
    Table 1. Parkinson’s Disease Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Parkinson’s Disease Therapeutics Market Trends
    Table 3. Parkinson’s Disease Therapeutics Market Drivers
    Table 4. Parkinson’s Disease Therapeutics Market Challenges
    Table 5. Parkinson’s Disease Therapeutics Market Restraints
    Table 6. Global Parkinson’s Disease Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Parkinson’s Disease Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Parkinson’s Disease Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Parkinson’s Disease Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Parkinson’s Disease Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Parkinson’s Disease Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Parkinson’s Disease Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Parkinson’s Disease Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Parkinson’s Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2021)
    Table 15. Top Players of Parkinson’s Disease Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Parkinson’s Disease Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Parkinson’s Disease Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Parkinson’s Disease Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Parkinson’s Disease Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Parkinson’s Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Parkinson’s Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Parkinson’s Disease Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Parkinson’s Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Parkinson’s Disease Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Parkinson’s Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Parkinson’s Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Parkinson’s Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbvie Company Details
    Table 31. Abbvie Business Overview
    Table 32. Abbvie Parkinson’s Disease Therapeutics Product
    Table 33. Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. Abbvie Recent Development
    Table 35. Biogen Company Details
    Table 36. Biogen Business Overview
    Table 37. Biogen Parkinson’s Disease Therapeutics Product
    Table 38. Biogen Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Biogen Recent Development
    Table 40. Boehringer Ingelheim GmbH Company Details
    Table 41. Boehringer Ingelheim GmbH Business Overview
    Table 42. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product
    Table 43. Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Boehringer Ingelheim GmbH Recent Development
    Table 45. F. Hoffman-La Roche Company Details
    Table 46. F. Hoffman-La Roche Business Overview
    Table 47. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product
    Table 48. F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. F. Hoffman-La Roche Recent Development
    Table 50. GlaxoSmithKline Company Details
    Table 51. GlaxoSmithKline Business Overview
    Table 52. GlaxoSmithKline Parkinson’s Disease Therapeutics Product
    Table 53. GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. GlaxoSmithKline Recent Development
    Table 55. H. Lundbeck A/S Company Details
    Table 56. H. Lundbeck A/S Business Overview
    Table 57. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product
    Table 58. H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. H. Lundbeck A/S Recent Development
    Table 60. Impax Labs Company Details
    Table 61. Impax Labs Business Overview
    Table 62. Impax Labs Parkinson’s Disease Therapeutics Product
    Table 63. Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Impax Labs Recent Development
    Table 65. Newron Pharmaceuticals SpA Company Details
    Table 66. Newron Pharmaceuticals SpA Business Overview
    Table 67. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product
    Table 68. Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. Newron Pharmaceuticals SpA Recent Development
    Table 70. Novartis AG Company Details
    Table 71. Novartis AG Business Overview
    Table 72. Novartis AG Parkinson’s Disease Therapeutics Product
    Table 73. Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 74. Novartis AG Recent Development
    Table 75. Orion Corporation Company Details
    Table 76. Orion Corporation Business Overview
    Table 77. Orion Corporation Parkinson’s Disease Therapeutics Product
    Table 78. Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 79. Orion Corporation Recent Development
    Table 80. Teva Pharmaceutical Industries Ltd. Company Details
    Table 81. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 82. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product
    Table 83. Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 84. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 85. UCB S.A. Company Details
    Table 86. UCB S.A. Business Overview
    Table 87. UCB S.A. Parkinson’s Disease Therapeutics Product
    Table 88. UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 89. UCB S.A. Recent Development
    Table 90. Livzon Pharmaceutical Company Details
    Table 91. Livzon Pharmaceutical Business Overview
    Table 92. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product
    Table 93. Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 94. Livzon Pharmaceutical Recent Development
    Table 95. Haisco Pharmaceutical Company Details
    Table 96. Haisco Pharmaceutical Business Overview
    Table 97. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product
    Table 98. Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 99. Haisco Pharmaceutical Recent Development
    Table 100. Jingxin Pharmaceutical Company Details
    Table 101. Jingxin Pharmaceutical Business Overview
    Table 102. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product
    Table 103. Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 104. Jingxin Pharmaceutical Recent Development
    Table 105. Dongcheng Biochemicals Company Details
    Table 106. Dongcheng Biochemicals Business Overview
    Table 107. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product
    Table 108. Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 109. Dongcheng Biochemicals Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Parkinson’s Disease Therapeutics Product Picture
    Figure 2. Global Parkinson’s Disease Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Parkinson’s Disease Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Parkinson’s Disease Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Parkinson’s Disease Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Parkinson’s Disease Therapeutics Market Share in Global 2017-2028
    Figure 7. Parkinson’s Disease Therapeutics Report Years Considered
    Figure 8. Product Picture of Oral
    Figure 9. Product Picture of Transdermal
    Figure 10. Product Picture of Subcutaneous
    Figure 11. Product Picture of Intestinal Infusion
    Figure 12. Global Parkinson’s Disease Therapeutics Market Share by Type in 2022 & 2028
    Figure 13. Global Parkinson’s Disease Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Parkinson’s Disease Therapeutics Market Share by Type (2017-2028)
    Figure 15. United States Parkinson’s Disease Therapeutics Market Share by Type in 2022 & 2028
    Figure 16. United States Parkinson’s Disease Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Parkinson’s Disease Therapeutics Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Others
    Figure 21. Global Parkinson’s Disease Therapeutics Market Share by Application in 2022 & 2028
    Figure 22. Global Parkinson’s Disease Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Parkinson’s Disease Therapeutics Market Share by Application (2017-2028)
    Figure 24. United States Parkinson’s Disease Therapeutics Market Share by Application in 2022 & 2028
    Figure 25. United States Parkinson’s Disease Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Parkinson’s Disease Therapeutics Market Share by Application (2017-2028)
    Figure 27. North America Parkinson’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. United States Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Parkinson’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Parkinson’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. China Taiwan Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Parkinson’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UAE Parkinson’s Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Abbvie Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 55. Biogen Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 56. Boehringer Ingelheim GmbH Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 57. F. Hoffman-La Roche Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 59. H. Lundbeck A/S Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 60. Impax Labs Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 61. Newron Pharmaceuticals SpA Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 62. Novartis AG Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 63. Orion Corporation Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 64. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 65. UCB S.A. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 66. Livzon Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 67. Haisco Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 68. Jingxin Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 69. Dongcheng Biochemicals Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed